Ignite Creation Date:
2025-12-24 @ 5:57 PM
Ignite Modification Date:
2025-12-27 @ 9:15 PM
Study NCT ID:
NCT00351468
Status:
COMPLETED
Last Update Posted:
2017-04-17
First Post:
2006-07-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
EXTEND (Eltrombopag Extended Dosing Study)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06
Start Date Type:
None
Primary Completion Date:
2015-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-07
Completion Date Type:
ACTUAL
First Submit Date:
2006-07-10
First Submit QC Date:
None
Study First Post Date:
2006-07-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-07-06
Results First Submit QC Date:
None
Results First Post Date:
2017-04-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-05
Last Update Post Date:
2017-04-17
Last Update Post Date Type:
ACTUAL